Literature DB >> 24677727

Proteases and proteomics: cutting to the core of human skin pathologies.

Simon J de Veer1, Laetitia Furio, Jonathan M Harris, Alain Hovnanian.   

Abstract

Preserving the integrity of the skin's outermost layer (the epidermis) is vital for humans to thrive in hostile surroundings. Covering the entire body, the epidermis forms a thin but impenetrable cellular cordon that repels external assaults and blocks escape of water and electrolytes from within. This structure exists in a perpetual state of regeneration where the production of new cellular subunits at the base of the epidermis is offset by the release of terminally differentiated corneocytes from the surface. It is becoming increasingly clear that proteases hold vital roles in assembling and maintaining the epidermal barrier. More than 30 proteases are expressed by keratinocytes or infiltrating immune cells and the activity of each must be maintained within narrow limits and confined to the correct time and place. Accordingly, over- or under-exertion of proteolytic activity is a common factor in a multitude of skin disorders that range in severity from relatively mild to life-threatening. This review explores the current state of knowledge on the involvement of proteases in skin diseases and the latest findings from proteomic and transcriptomic studies focused on uncovering novel (patho)physiological roles for these enzymes.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Epidermis; Inflammation; Keratinocyte; Permeability barrier; Therapeutic target

Mesh:

Substances:

Year:  2014        PMID: 24677727     DOI: 10.1002/prca.201300081

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  11 in total

Review 1.  Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration.

Authors:  Ninad Varkhede; Rupesh Bommana; Christian Schöneich; M Laird Forrest
Journal:  J Pharm Sci       Date:  2019-08-10       Impact factor: 3.534

2.  Expression of the Ly6/uPAR-domain proteins C4.4A and Haldisin in non-invasive and invasive skin lesions.

Authors:  Mette C Kriegbaum; Ole P F Clausen; Ole D Lærum; Michael Ploug
Journal:  J Histochem Cytochem       Date:  2014-11-20       Impact factor: 2.479

3.  Loss-of-Function Mutations in SERPINB8 Linked to Exfoliative Ichthyosis with Impaired Mechanical Stability of Intercellular Adhesions.

Authors:  Manuela Pigors; Ofer Sarig; Lisa Heinz; Vincent Plagnol; Judith Fischer; Janan Mohamad; Natalia Malchin; Shefali Rajpopat; Monia Kharfi; Giles G Lestringant; Eli Sprecher; David P Kelsell; Diana C Blaydon
Journal:  Am J Hum Genet       Date:  2016-07-28       Impact factor: 11.025

4.  KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.

Authors:  Laetitia Furio; Georgios Pampalakis; Iacovos P Michael; Andras Nagy; Georgia Sotiropoulou; Alain Hovnanian
Journal:  PLoS Genet       Date:  2015-09-21       Impact factor: 5.917

5.  C4.4A gene ablation is compatible with normal epidermal development and causes modest overt phenotypes.

Authors:  Mette Camilla Kriegbaum; Benedikte Jacobsen; Annette Füchtbauer; Gert Helge Hansen; Ib Jarle Christensen; Carsten Friis Rundsten; Morten Persson; Lars Henning Engelholm; Andreas Nygaard Madsen; Ivano Di Meo; Ida Katrine Lund; Birgitte Holst; Andreas Kjaer; Ole Didrik Lærum; Ernst-Martin Füchtbauer; Michael Ploug
Journal:  Sci Rep       Date:  2016-05-12       Impact factor: 4.379

6.  Topical Delivery of Rapamycin by Means of Microenvironment-Sensitive Core-Multi-Shell Nanocarriers: Assessment of Anti-Inflammatory Activity in an ex vivo Skin/T Cell Co-Culture Model.

Authors:  Fiorenza Rancan; Xiao Guo; Keerthana Rajes; Polytimi Sidiropoulou; Fatemeh Zabihi; Luisa Hoffmann; Sabrina Hadam; Ulrike Blume-Peytavi; Eckart Rühl; Rainer Haag; Annika Vogt
Journal:  Int J Nanomedicine       Date:  2021-10-22

7.  Proteomic signatures for perioperative oxygen delivery in skin after major elective surgery: mechanistic sub-study of a randomised controlled trial.

Authors:  Wendy E Heywood; Emily Bliss; Fatima Bahelil; Trinda Cyrus; Marilena Crescente; Timothy Jones; Sadaf Iqbal; Laura G Paredes; Andrew J Toner; Ana G Del Arroyo; Edel A O'Toole; Kevin Mills; Gareth L Ackland
Journal:  Br J Anaesth       Date:  2021-07-06       Impact factor: 11.719

8.  An optimised method for the proteomic profiling of full thickness human skin.

Authors:  Emily Bliss; Wendy E Heywood; Malika Benatti; Neil J Sebire; Kevin Mills
Journal:  Biol Proced Online       Date:  2016-07-21       Impact factor: 3.244

9.  Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure-Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects.

Authors:  Robert Palmér; Jukka Mäenpää; Alexandra Jauhiainen; Bengt Larsson; John Mo; Muir Russell; James Root; Susanne Prothon; Ligia Chialda; Pablo Forte; Torbjörn Egelrud; Kristina Stenvall; Philip Gardiner
Journal:  Clin Pharmacol Ther       Date:  2018-04-16       Impact factor: 6.875

10.  Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers.

Authors:  Janna Frombach; Fiorenza Rancan; Katharina Kübrich; Fabian Schumacher; Michael Unbehauen; Ulrike Blume-Peytavi; Rainer Haag; Burkhard Kleuser; Robert Sabat; Kerstin Wolk; Annika Vogt
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.